Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

Sinobiopharma (SNBP) soars!

Today's Financial News - Posted November 17, 2009

big.chartChinese pharma hopeful Sinobiopharma (OTC:SNBP) has been soaring — gaining over 70% in three trading days. Good news for Hot Stock Confidential members who’ve been holding this stock through its slum. And GREAT news for members of TFN’s high-end service, Penny Stock Confidential, who bagged 68.4% in just ten trading days!

by J. Christoph Amberger

Baltimore, MD — TFN: It’s the stuff penny stock legends are made of: Pick up shares in a promising company for a few cents… and walk away with a pocket full of cash a week later!

One of our Chinese pharma “proxy” stocks, Sinobiopharma (OTC:SNBP), has been soaring for two days straight! If you’re one of our steady TFN friends, you’re familiar with this stock. Our Hot Stock Condfidential members have been buying it anywhere between 17 cents and 34 cents since this summer. And our venturesome Penny Stock Confidential members picked it up last week between 17 cents and 19 cents a share.

(I know, I know. As penny stock punters, we’re in for the big, big gains. Doubles, triples, quadruples. But 68% gains in a week were just too good to pass up!)

The stock rose on strangely informative news… namely, that “23 generic drugs for which the Company has production rights are listed in China’s National Essential Drugs List, which covers pharmaceuticals used to treat up to 80 percent of the most common diseases in China.”

Earnings are great. Net is great. But this hasn’t kept the stock from falling for most of the year.

HSC members will be holding on to our position. PSC members are getting ready to reinvest the gains in another promising penny stock I just dug up.

(Do me a favor and check out what we’re up to with Penny Stock Confidential. We’ve only been available for membership for ten days, and already produced gains of 43% and 68%. Just click here…)


Next Article: Worried about the dollar?

Be the first to leave a reply.

Your comments are welcome